159 related articles for article (PubMed ID: 12808445)
1. Structure of human dCK suggests strategies to improve anticancer and antiviral therapy.
Sabini E; Ort S; Monnerjahn C; Konrad M; Lavie A
Nat Struct Biol; 2003 Jul; 10(7):513-9. PubMed ID: 12808445
[TBL] [Abstract][Full Text] [Related]
2. Docking simulation with a purine nucleoside specific homology model of deoxycytidine kinase, a target enzyme for anticancer and antiviral therapy.
Johnsamuel J; Eriksson S; Oliveira M; Tjarks W
Bioorg Med Chem; 2005 Jul; 13(13):4160-7. PubMed ID: 15876539
[TBL] [Abstract][Full Text] [Related]
3. Structural basis for the preference of UTP over ATP in human deoxycytidine kinase: illuminating the role of main-chain reorganization.
Godsey MH; Ort S; Sabini E; Konrad M; Lavie A
Biochemistry; 2006 Jan; 45(2):452-61. PubMed ID: 16401075
[TBL] [Abstract][Full Text] [Related]
4. The structure of human deoxycytidine kinase in complex with clofarabine reveals key interactions for prodrug activation.
Zhang Y; Secrist JA; Ealick SE
Acta Crystallogr D Biol Crystallogr; 2006 Feb; 62(Pt 2):133-9. PubMed ID: 16421443
[TBL] [Abstract][Full Text] [Related]
5. Structures of human deoxycytidine kinase product complexes.
Soriano EV; Clark VC; Ealick SE
Acta Crystallogr D Biol Crystallogr; 2007 Dec; 63(Pt 12):1201-7. PubMed ID: 18084067
[TBL] [Abstract][Full Text] [Related]
6. [Special function of deoxycytidine kinase (dCK) in the activation of chemotherapeutic nucleoside analogs and in the inhibition of cell proliferation].
Staub M
Magy Onkol; 2004; 48(3):229-34. PubMed ID: 15520873
[TBL] [Abstract][Full Text] [Related]
7. Fluorescence energy transfer studies of human deoxycytidine kinase: role of cysteine 185 in the conformational changes that occur upon substrate binding.
Mani RS; Usova EV; Cass CE; Eriksson S
Biochemistry; 2006 Mar; 45(11):3534-41. PubMed ID: 16533034
[TBL] [Abstract][Full Text] [Related]
8. Structural basis for substrate promiscuity of dCK.
Sabini E; Hazra S; Ort S; Konrad M; Lavie A
J Mol Biol; 2008 May; 378(3):607-21. PubMed ID: 18377927
[TBL] [Abstract][Full Text] [Related]
9. Activation of deoxycytidine kinase by protein kinase inhibitors and okadaic acid in leukemic cells.
Smal C; Cardoen S; Bertrand L; Delacauw A; Ferrant A; Van den Berghe G; Van Den Neste E; Bontemps F
Biochem Pharmacol; 2004 Jul; 68(1):95-103. PubMed ID: 15183121
[TBL] [Abstract][Full Text] [Related]
10. Human deoxycytidine kinase as a deoxyribonucleoside phosphorylase.
Usova E; Maltseva T; Földesi A; Chattopadhayaya J; Eriksson S
J Mol Biol; 2004 Dec; 344(5):1347-58. PubMed ID: 15561147
[TBL] [Abstract][Full Text] [Related]
11. Arabinosylguanine is phosphorylated by both cytoplasmic deoxycytidine kinase and mitochondrial deoxyguanosine kinase.
Rodriguez CO; Mitchell BS; Ayres M; Eriksson S; Gandhi V
Cancer Res; 2002 Jun; 62(11):3100-5. PubMed ID: 12036920
[TBL] [Abstract][Full Text] [Related]
12. Novel potent inhibitors of deoxycytidine kinase identified and compared by multiple assays.
Yu XC; Miranda M; Liu Z; Patel S; Nguyen N; Carson K; Liu Q; Swaffield JC
J Biomol Screen; 2010 Jan; 15(1):72-9. PubMed ID: 19959816
[TBL] [Abstract][Full Text] [Related]
13. The sugar ring of the nucleoside is required for productive substrate positioning in the active site of human deoxycytidine kinase (dCK): implications for the development of dCK-activated acyclic guanine analogues.
Hazra S; Konrad M; Lavie A
J Med Chem; 2010 Aug; 53(15):5792-800. PubMed ID: 20684612
[TBL] [Abstract][Full Text] [Related]
14. A pre-steady-state kinetic analysis of substrate binding to human recombinant deoxycytidine kinase: a model for nucleoside kinase action.
Turk B; Awad R; Usova EV; Björk I; Eriksson S
Biochemistry; 1999 Jun; 38(26):8555-61. PubMed ID: 10387103
[TBL] [Abstract][Full Text] [Related]
15. Influence of phosphorylation of THR-3, SER-11, and SER-15 on deoxycytidine kinase activity and stability.
Smal C; Ntamashimikiro S; Arts A; Van Den Neste E; Bontemps F
Nucleosides Nucleotides Nucleic Acids; 2010 Jun; 29(4-6):404-7. PubMed ID: 20544527
[TBL] [Abstract][Full Text] [Related]
16. Activation of deoxycytidine kinase by deoxyadenosine: implications in deoxyadenosine-mediated cytotoxicity.
Keszler G; Virga S; Spasokoukotskaja T; Bauer PI; Sasvari-Szekely M; Staub M
Arch Biochem Biophys; 2005 Apr; 436(1):69-77. PubMed ID: 15752710
[TBL] [Abstract][Full Text] [Related]
17. Hydrodynamic and spectroscopic studies of substrate binding to human recombinant deoxycytidine kinase.
Mani RS; Usova EV; Eriksson S; Cass CE
Nucleosides Nucleotides Nucleic Acids; 2003 Feb; 22(2):175-92. PubMed ID: 12744604
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of the role of three candidate human kinases in the conversion of the hepatitis C virus inhibitor 2'-C-methyl-cytidine to its 5'-monophosphate metabolite.
Golitsina NL; Danehy FT; Fellows R; Cretton-Scott E; Standring DN
Antiviral Res; 2010 Mar; 85(3):470-81. PubMed ID: 19883694
[TBL] [Abstract][Full Text] [Related]
19. Nonenantioselectivity property of human deoxycytidine kinase explained by structures of the enzyme in complex with L- and D-nucleosides.
Sabini E; Hazra S; Konrad M; Lavie A
J Med Chem; 2007 Jun; 50(13):3004-14. PubMed ID: 17530837
[TBL] [Abstract][Full Text] [Related]
20. Structural and kinetic characterization of human deoxycytidine kinase variants able to phosphorylate 5-substituted deoxycytidine and thymidine analogues .
Hazra S; Ort S; Konrad M; Lavie A
Biochemistry; 2010 Aug; 49(31):6784-90. PubMed ID: 20614893
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
